| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. KenChowder: For what it's worth, Dr. Max Lataillade is not (3382)  (23) |
| 2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (2615) |
| 3. My69z: Dr. Palmer / Ascletis : *Gannex, a wholly owned (1640) (9) |
| 4. riskreward007: Smart or not, she and army are both trying to (1205) (4) |
| 5. My69z: She left L'oreal for GlaxoSmithKline in May 2010. (1178) (5) |
| 6. Jake2212: " Syneos Health has helped to develop or (1069) (24) |
| 7. armyseal: Reality is hard to come by for many they simply (1059) (3) |
| 8. ohm20: It looks like Leronlimab will compliment (1058) (25) |
| 9. My69z: Consider this: Dr. Lataillade hiring; Nov. 2023 (931) (10) |
| 10. My69z: Gaudinski / GSK / VRC07-523LS: 2019 Pi on (926) (6) |
| 11. mightycydy: Re: CYDY's new hire - Dr. Max Lataillade Video (917) (8) |
| 12. My69z: Max/GSK/FDA/Fostemsavir: Meeting Category: (911) (18) |
| 13. BZE: Zero updates in 2023 on web archive but 5 updates (898) (2) |
| 14. ohm20: If that's correct (and please correct me if I'm (809) (26) |
| 15. Katangolo: Love seeing us partnering. Little CYDY is growing (779) (12) |
| 16. ohm20: Leronlimab - Disease List (currently 90) (updated (777) (28) |
| 17. Plotinus: It would be of interest to see the protocol for (776) (25) |
| 18. ohm20: fixed your post viewed as too crazy at the (772) (8) |
| 19. My69z: Did not realize GSK's R&D focus is the immune (754) (5) |
| 20. Jake2212: Perhaps TAK, not MRK, lies in LL's future. We all (751) (32) |
| 21. USS JOHNSTON: The United States is the greatest nation on God's (745) (17) |
| 22. Katangolo: 700k shares were Rangebound by 0.02 cents since (743) (6) |
| 23. Evil Rabbit: This is off-topic and there are many many (729) (15) |
| 24. dfwl28: Thanks ohm. Good news. This could eliminate most (723) (5) |
| 25. biloxiblues: I think everything hinges on what comes back from (716) (14) |
| 26. Albert364: Love International Group, Inc. (LOVV) is a (708) |
| 27. biloxiblues: https://www.foxnews.com/media/rfk-jr-wants-clear- (701) (9) |
| 28. ohm20: Cytodyn doesn’t have enough $ resources to (697) (17) |
| 29. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (685) |
| 30. dfwl28: https://www.globenewswire.com/news-release/2024/1 (680) (6) |
| 31. My69z: Started 2018 related to resevoir: Here, we (679) (3) |
| 32. chazzledazzle: I agree with you both. The Janet Woodcock email (679) (6) |
| 33. Biolyfe: Board of directors. So to Jump Right In, I'll (673) (23) |
| 34. My69z: LL / CCL4: Jan. 2021. "Leronlimab blocks CCL5, (668) (6) |
| 35. My69z: MD/GSK/AISC: 2013: Oncology Clinical and (667) (7) |
| 36. cardamine: Just as a positive future indicator amid all this (658) (21) |
| 37. MGK_2: Exactly cardamine. Most of the impurities have (652) (6) |
| 38. Drano: And that is exactly why this Pestell garbage has (649) (5) |
| 39. Katangolo: Looking more and more likely that the PDL-1s are (640) (13) |
| 40. MJS719: From Reddit: More research driven use for (639) (13) |
| 41. biloxiblues: https://www.reddit.com/r/Livimmune/comments/1gryd (639) (6) |
| 42. Respert24: I do think it's smart to get a question or two (635) (31) |
| 43. Figgs: I do not need to see anything but totally (635) (17) |
| 44. Niele: As the share price dips, we are here bickering (632) (26) |
| 45. ohm20: New opinion piece by 3 prominent researchers (632) (26) |
| 46. cardamine: Great and we're the first co listed in the body (631) (8) |
| 47. My69z: Sean, GSK CEO E. Walmsley... Sept. 2021 " The (627) (3) |
| 48. 2MartiniGi: Well, just speaking for myself, I'm on here to (625) (24) |
| 49. Evil Rabbit: Someone posted on Stock Twits that Eagle Bay, the (619) (15) |
| 50. Respert24: Hard pass for me on that link. I think what (617) (32) |
